XY0YX37
XY0YX37 — Extracorporeal Introduction of Nafamostat Anticoagulant, New Technology Group 7
Billable / specific codeICD-10-PCS
CMS abbreviated title: Extracorporeal Introduction of Nafamostat, New Tech 7
How XY0YX37 is built
Every ICD-10-PCS code is seven independent character positions. Each one is a separate decision, and the meaning of a character depends on the positions before it.
- XSectionNew Technology — What family of procedure this is
- YBody systemWhich system it acts on
- 0Root operationThe objective — the verb of the procedure
- YBody partThe specific site
- XApproachHow the site was reached
- 3DeviceWhat was left in place, if anything
- 7QualifierA further distinction where one applies
Codes near XY0YX37
In CMS’s own ordering, which groups codes that differ by only the last character or two — usually the approach, device or qualifier.
- XXE5XV7Measurement of Infection, Serum/Plasma Nanoparticle Fluorescence SARS-CoV-2 Antibody Detection, New Technology Group 7
- XXE5XY9Measurement of Infection, Other Positive Blood/Isolated Colonies Bimodal Phenotypic Susceptibility Technology, New Technology Group 9
- XXE97U7Measurement of Infection, Nasopharyngeal Fluid SARS-CoV-2 Polymerase Chain Reaction, New Technology Group 7
- XXEZXABMeasurement of Macronutrient Content, Computer-aided Assessment for Nutrition Management, New Technology Group 11
- XXEZXCBMeasurement of Infection, Computer-aided Triage and Notification, New Technology Group 11
- XY0VX83Extracorporeal Introduction of Endothelial Damage Inhibitor to Vein Graft, New Technology Group 3
- XY0YX28Extracorporeal Introduction of Taurolidine Anti-infective and Heparin Anticoagulant, New Technology Group 8
- XY0YX37Extracorporeal Introduction of Nafamostat Anticoagulant, New Technology Group 7